期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
净肠茶的致突变作用研究
1
作者 张白嘉 赵军宁 +3 位作者 杨亚斯 谭正怀 王晓东 戴瑛 《四川生理科学杂志》 1999年第3期27-29,共3页
本文通过小鼠显性致死试验及小鼠骨髓多染红细胞微核试验的检测,观察了灌胃给予净肠茶有无致突变潜在毒性。结果表明,在本试验剂量范围内,观测到净肠茶对小鼠生殖细胞、骨髓多染红细胞无致突变作用。
关键词 净肠 显性致死试验 微核试验 致突变作用
下载PDF
净肠茶致畸敏感期毒性实验研究
2
作者 王晓东 张白嘉 +1 位作者 谭正怀 赵军宁 《四川生理科学杂志》 1999年第1期40-41,共2页
净肠茶能润肠、通便、降脂,主要用于预防和治疗中老年人便秘和高脂血症。我们在受孕大鼠的胚胎着床后并已开始进入细胞及器官分化期,灌胃给予净肠茶,观察该制剂对大鼠致畸敏感期毒性作用。结果净肠茶3、6和12g(相当于配方原料量)/kg(分... 净肠茶能润肠、通便、降脂,主要用于预防和治疗中老年人便秘和高脂血症。我们在受孕大鼠的胚胎着床后并已开始进入细胞及器官分化期,灌胃给予净肠茶,观察该制剂对大鼠致畸敏感期毒性作用。结果净肠茶3、6和12g(相当于配方原料量)/kg(分别相当于人群推荐剂量的100、200和400倍)三个剂量组,对孕鼠各项指标(孕鼠增重、黄体数、吸收胎数、活胎数、死胎数、窝重)及胎鼠各项指标(雌雄比例、身长、尾长、体重、胎盘重、外观、骨骼、内脏)均无明显影响。 展开更多
关键词 净肠 致畸试验 大鼠
下载PDF
口服净肠饮代替清洁灌肠法的实验研究及临床应用 被引量:4
3
作者 龚美娴 艾惠兰 柳永红 《中华护理杂志》 CSCD 北大核心 1993年第5期259-261,共3页
临床上在进行腹部X线拍片检查时,常需采用传统的清洁灌肠法作肠道准备,但有时因肠内的气体、粪便多且与结石阴影相重叠,而影响拍片效果。为了寻求能代替传统灌肠法的中药口服方剂,首先进行药物筛选,确定净肠饮方剂,并做了动物实验,然后... 临床上在进行腹部X线拍片检查时,常需采用传统的清洁灌肠法作肠道准备,但有时因肠内的气体、粪便多且与结石阴影相重叠,而影响拍片效果。为了寻求能代替传统灌肠法的中药口服方剂,首先进行药物筛选,确定净肠饮方剂,并做了动物实验,然后进行前瞻性的临床研究,对口服净肠饮与传统的清洁灌肠法随机做平行对照试验。通过三年的临床应用及对150例(对照组50例,实验组100例)病人的临床观察,证实中药净肠饮具有清洁肠道的作用,能排净粪便和气体。临床拍片的质量分析结果,实验组优良者占98%,对照组优良者占88%.经统计学处理P<0.01。 展开更多
关键词 口服 净肠 清洁灌 临床
原文传递
中药制剂洁肠净片在临床影像学检查中的应用
4
作者 王志勤 王勇 +2 位作者 王奇咏 孟晓红 姬斌 《中国中西医结合影像学杂志》 2007年第6期444-444,共1页
关键词 影像学检查 道清洁
下载PDF
净腑洁肠汤联合氢化可的松灌肠治疗溃疡性结肠炎
5
作者 谭远忠 徐奔 《湖北中医杂志》 2007年第12期35-36,共2页
关键词 溃疡性结 中西医结合疗法 腑洁 氢化可的松
下载PDF
减肥降糖说荞麦
6
作者 元秀 《开卷有益(求医问药)》 2019年第2期62-62,共1页
荞麦又名净肠草、鹿蹄草、莜麦,为蓼科植物荞麦的种子,是一种极具营养价值的谷类食物。其性凉,味甘,健胃消积,止汗。适宜食欲不振、肠胃积滞、慢性泄泻之人食用。《本草求真》载:'凡白浊、泄痢、痘疮溃疡,气盛实热等症,是其所宜。'
关键词 极具 鹿蹄草 荞麦 粮种 痘疮 净肠 又名
下载PDF
一腔热血化甘霖 枝枝叶叶总为情——记河南平顶山平武煤矿青年六矿矿长李国强
7
作者 刘宏民 高建军 《决策探索》 2004年第5期78-79,共2页
关键词 河南平顶山平武煤矿青年六矿 李国强 安全责任制 教育事业 玉带河 净肠 人民政协代表
下载PDF
Expression,purification and characterization of enterovirus-71 virus-like particles 被引量:43
8
作者 Yao-Chi Chung Jen-Huang Huang +4 位作者 Chia-Wei Lai Heng-Chun Sheng Shin-Ru Shih Mei-Shang Ho Yu-Chen Hu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第6期921-927,共7页
AIM: Enterovirus 71 (EV71) has been implicated as the etiological agent responsible for the recent outbreaks of hand, foot and mouth disease associated with severe neurological diseases in the Asia-Pacific region. ... AIM: Enterovirus 71 (EV71) has been implicated as the etiological agent responsible for the recent outbreaks of hand, foot and mouth disease associated with severe neurological diseases in the Asia-Pacific region. METHODS: The assembly process was hypothesized to occur via an orchestrated proteolytic processing of the P1 precursor by the viral protease 3CD. To test this hypothesis, we constructed 3 recombinant baculoviruses: Bac-P1 expressing P1; Bac-3CD expressing 3CD; and Bac-P1-3CD co-expressing P1 and 3CD. RESULTS: Both single infection by Bac-P1-3CD and coinfection by Bac-P1 and Bac-3CD resulted in correct cleavage of P1 to yield individual proteins VP0, VP1 and VP3, while the former approach yielded higher VLP production. In the cells, the structural proteins selfassembled into clusters of virus-like particles (VLP) resembling the authentic EV71 particle aggregates. After ultracentrifugation purification, the dispersed VLPs were indistinguishable from the authentic virus in size, appearance, composition and surface epitopes, as determined by SDS-PAGE, Western blot, transmission electron microscopy and immunogold labeling. CONCLUSION: Our data, for the first time, suggest that in insect cells EV71 structural proteins adopt a processing and assembly pathway similar to poliovirus assembly. The preservation of particle morphology and composition suggest that the VLP may be a valuable vaccine candidate to prevent EV71 epidemics. 展开更多
关键词 Enterovirus 71 Virus-like particle VLP VACCINE BACULOVIRUS Insect cell
下载PDF
Receptor-binding domain of SARS-Cov spike protein: Soluble expression in E.coli, purification and functional characterization 被引量:2
9
作者 Jing Chen Lin Miao +5 位作者 Jia-Ming Li Yan-Ying Li Qing-Yu Zhu Chang-Lin Zhou Hong-Qing Fang Hui-Peng Chen 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第39期6159-6164,共6页
AIM: To find a soluble and functional recombinant receptor-binding domain of severe acute respiratory syndrome-associated coronavirus (SARS-Cov), and to analyze its receptor binding ability. METHODS: Three fusion ... AIM: To find a soluble and functional recombinant receptor-binding domain of severe acute respiratory syndrome-associated coronavirus (SARS-Cov), and to analyze its receptor binding ability. METHODS: Three fusion tags (glutathione S-transferase, GST; thioredoxin, Trx; maltose-binding protein, MBP), which preferably contributes to increasing solubility and to facilitating the proper folding of heteroprotein, were used to acquire the soluble and functional expression of RBD protein in Escherichia coli (BL21(DE3) and Rosetta-gamiB (DE3) strains). The receptor binding ability of the purified soluble RBD protein was then detected by ELISA and flow cytometry assay. RESULTS: RBD of SARS-Cov spike protein was expressed as inclusion body when fused as TrxA tag form in both BL21 (DE3) and Rosetta-gamiB (DE3) under many different cultures and induction conditions. And there was no visible expression band on SDS-PAGE when RBD was expressed as MBP tagged form. Only GST tagged RBD was soluble expressed in BL21(DE3), and the protein was purified by AKTA Prime Chromatography system. The ELISA data showed that GST.RBD antigen had positive reaction with anti-RBD mouse monoclonal antibody 1A5. Further flow cytometry assay demonstrated the high efficiency of RBD's binding ability to ACE2 (angiotensin-converting enzyme 2) positive Vero E6 cell. And ACE2 was proved as a cellular receptor that meditated an initial-affinity interaction with SARS-Cov spike protein. The geometrical mean of GST and GST.RBD binding to Vero E6 cells were 77.08 and 352.73 respectively. CONCLUSION: In this paper, we get sufficient soluble N terminal GST tagged RBD protein expressed in EcoliBL21 (DE3); data from ELISA and flow cytometry assay demonstrate that the recombinant protein is functional and binding to ACE2 positive Vero E6 cell efficiently. And the recombinant RBD derived from E.coli can be used to developing subunit vaccine to block S protein binding with receptor and to neutralizing SARS-Cov infection. 展开更多
关键词 Receptor-binding domain SARS-COV Spike protein expression E.COLI
下载PDF
Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: A pilot, prospective, multicenter, randomized study 被引量:4
10
作者 Elena Ricart Maria Esteve +6 位作者 Montserrat Andreu Francesc Casellas David Monfort Miquel Sans Natalia Oudovenko Raúl Lafuente Julián Panés 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第15期2193-2197,共5页
AIM: To evaluate the efficacy of 5 compared to :tO granulocyteaphaeresis sessions in patients with active steroid-dependent ulcerative colitis. METHODS: In this pilot, prospective, multicenter randomized trial, 20 ... AIM: To evaluate the efficacy of 5 compared to :tO granulocyteaphaeresis sessions in patients with active steroid-dependent ulcerative colitis. METHODS: In this pilot, prospective, multicenter randomized trial, 20 patients with moderately active steroid-dependent ulcerative colitis were randomized to 5 or 10 granulocyteaphaeresis sessions. The primary objective was clinical remission at wk 17. Secondary measures included endoscopic remission and steroid consumption.RESULTS: Nine patients were randomized to 5 granulocyteaphaeresis sessions (group 1) and 11 patients to 10 granulocyteaphaeresis sessions (group 2). At wk 17, 37.5% of patients in group 1 and 45.45% of patients in group 2 were in clinical remission. Clinical remission was accompanied by endoscopic remission in all cases. Eighty-six percent of patients achieving remission were steroid-free at wk 17. Daily steroid requirements were significantly lower in group 2. Eighty-nine per cent of patients remained in remission during a one year follow-up. One serious adverse event, not related to the study therapy, was reported. CONCLUSION: Granulocyteaphaeresis is safe and effective for the treatment of steroid-dependent ulcerative colitis. In this population, increasing the number of aphaeresis sessions is not associated with higher remission rates, but affords a significant steroid-sparing effect. 展开更多
关键词 Ulcerative colitis Granulocyteaphaeresis Steroid-dependence Inflammatory bowel diease treatment
下载PDF
Production of human intestinal trefoil factor in Pichia pastoris
11
作者 孙勇 彭曦 +2 位作者 吕尚军 张勇 汪仕良 《Journal of Medical Colleges of PLA(China)》 CAS 2006年第4期203-208,共6页
Objective:To construct a Pichia pastoris (P. pastoris) expression vector of human intestinal trefoil factor (hITF) and study its expression and purification procedures. Methods:hITF gene encoding mature peptide ... Objective:To construct a Pichia pastoris (P. pastoris) expression vector of human intestinal trefoil factor (hITF) and study its expression and purification procedures. Methods:hITF gene encoding mature peptide was modified with a polybistidine tag sequence at the N-terminal, and then inserted into the P. pastoris expression vector pGAPZaA at the downstream of the s-mating factor signal. After gene sequencing, the recombinant pGAPZaA-hITF was transformed into the P. pastoris strain X-33 with lithium chloride, rhITF was induced to constitutively express in shake flask, and then analyzed with Tricine SDS-PAGEand Western blotting. The obtained rhITF was isolated from the cultured supernatants by ammonium sulfate precipitation, Ni-NTA affinity chromatography, and ultrafiltration. Results:The correctness and integrity of rhITF were identified by restriction digestion and gene sequencing, rhITF was successfully expressed to 50 mg/L as a secretive protein. After purification, the purity was above 95%. Tricine SDS-PAGE and Western-blot analysis showed that rhITF presented as a single band with a molecular weight of 10 kDa, a little larger than 7 879 Da as assayed by mass spectrometry analysis. Conclusion: hITF P. pastoris expression vector is successfully constructed and rhITF is expressed in P. pastoris at commercially relevant level. This research lays foundation for the further functional studying of hITF. 展开更多
关键词 intestinal trefoil factor Pichia pastoris secretory expression PURIFICATION
下载PDF
Purification and identification of simian parvovirus protein Vp2 expressed in E.coli
12
作者 ZHENG WEN LIU YONG LIE CHU KEVIN E.BROWN 《Journal of Microbiology and Immunology》 2005年第3期219-223,共5页
To purify and identify the simian parvovirus (SPV) protein Vp2 expressed in E. coli, fusion protein of SPV Vp2 was expressed in E. coli DHSα competent cells transformed with vector pThioHis AVp2, and the new bacter... To purify and identify the simian parvovirus (SPV) protein Vp2 expressed in E. coli, fusion protein of SPV Vp2 was expressed in E. coli DHSα competent cells transformed with vector pThioHis AVp2, and the new bacterial protein extraction reagent was used to extract the protein. Detergents with different characteristics were used to solubilize the fusion protein, and metal chelating resin (ProBond) with a continuous elusion polyacrylamide gel electrophoresis procedure was employed to purify the fusion protein. SDS-PAGE gel stained with coomassie blue and Western-blotting probed with anti-thio and anti-SPV Vp2 antibodies were used to identify the specificity of the expressed and purified fusion proteins. It was found that the SPV Vp2 protein expressed in E. coli was highly insoluble, and could not be solublized by the commonly used detergent. However, 6 M urea could solubilize the fusion proteins and was then employed for the further purification procedure, but metal chelating resin could not be used for this procedure, because of the loss of the tertiary structure of HP-thiaoredoxin and the metal-binding domain. The technique with continuous elusion polyacrylamide gel electrophoresis yielded a homogenous protein with a single band on the gel stained with coomassie blue and retained reactivity with anti-thio or anti-SPV Vp2 antibodies. It is evident that this technique with successful purification of SPV Vp2 protein has practical significance for the further investigation on the simian parvovirus infection. 展开更多
关键词 Simian parvovirus Protein expression Protein purification
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部